Cargando…

A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid

Over the last decade, several studies demonstrated that prenylation of flavonoids enhances various biological activities as compared to the respective nonprenylated compounds. In line with this, the natural prenylated isoflavonoid alpinumisoflavone (AIF) has been explored for a number of biological...

Descripción completa

Detalles Bibliográficos
Autores principales: Ateba, Sylvin Benjamin, Mvondo, Marie Alfrede, Djiogue, Sefirin, Zingué, Stéphane, Krenn, Liselotte, Njamen, Dieudonné
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746831/
https://www.ncbi.nlm.nih.gov/pubmed/31551770
http://dx.doi.org/10.3389/fphar.2019.00952
_version_ 1783451762557976576
author Ateba, Sylvin Benjamin
Mvondo, Marie Alfrede
Djiogue, Sefirin
Zingué, Stéphane
Krenn, Liselotte
Njamen, Dieudonné
author_facet Ateba, Sylvin Benjamin
Mvondo, Marie Alfrede
Djiogue, Sefirin
Zingué, Stéphane
Krenn, Liselotte
Njamen, Dieudonné
author_sort Ateba, Sylvin Benjamin
collection PubMed
description Over the last decade, several studies demonstrated that prenylation of flavonoids enhances various biological activities as compared to the respective nonprenylated compounds. In line with this, the natural prenylated isoflavonoid alpinumisoflavone (AIF) has been explored for a number of biological and pharmacological effects (therapeutic potential). In this review, we summarize the current information on health-promoting properties of AIF. Reported data evidenced that AIF has a multitherapeutic potential with antiosteoporotic, antioxidant and anti-inflammatory, antimicrobial, anticancer, estrogenic and antiestrogenic, antidiabetic, and neuroprotective properties. However, research on these aspects of AIF is not sufficient and needs to be reevaluated using more appropriate methods and methodology. Further series of studies are needed to confirm these pharmacological effects, and this review should lay the basis for the design of respective investigations. Overall, despite the drawbacks of studies recorded, AIF exhibits a potential as drug candidate.
format Online
Article
Text
id pubmed-6746831
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67468312019-09-24 A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid Ateba, Sylvin Benjamin Mvondo, Marie Alfrede Djiogue, Sefirin Zingué, Stéphane Krenn, Liselotte Njamen, Dieudonné Front Pharmacol Pharmacology Over the last decade, several studies demonstrated that prenylation of flavonoids enhances various biological activities as compared to the respective nonprenylated compounds. In line with this, the natural prenylated isoflavonoid alpinumisoflavone (AIF) has been explored for a number of biological and pharmacological effects (therapeutic potential). In this review, we summarize the current information on health-promoting properties of AIF. Reported data evidenced that AIF has a multitherapeutic potential with antiosteoporotic, antioxidant and anti-inflammatory, antimicrobial, anticancer, estrogenic and antiestrogenic, antidiabetic, and neuroprotective properties. However, research on these aspects of AIF is not sufficient and needs to be reevaluated using more appropriate methods and methodology. Further series of studies are needed to confirm these pharmacological effects, and this review should lay the basis for the design of respective investigations. Overall, despite the drawbacks of studies recorded, AIF exhibits a potential as drug candidate. Frontiers Media S.A. 2019-09-10 /pmc/articles/PMC6746831/ /pubmed/31551770 http://dx.doi.org/10.3389/fphar.2019.00952 Text en Copyright © 2019 Ateba, Mvondo, Djiogue, Zingué, Krenn and Njamen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ateba, Sylvin Benjamin
Mvondo, Marie Alfrede
Djiogue, Sefirin
Zingué, Stéphane
Krenn, Liselotte
Njamen, Dieudonné
A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid
title A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid
title_full A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid
title_fullStr A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid
title_full_unstemmed A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid
title_short A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid
title_sort pharmacological overview of alpinumisoflavone, a natural prenylated isoflavonoid
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746831/
https://www.ncbi.nlm.nih.gov/pubmed/31551770
http://dx.doi.org/10.3389/fphar.2019.00952
work_keys_str_mv AT atebasylvinbenjamin apharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT mvondomariealfrede apharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT djioguesefirin apharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT zinguestephane apharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT krennliselotte apharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT njamendieudonne apharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT atebasylvinbenjamin pharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT mvondomariealfrede pharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT djioguesefirin pharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT zinguestephane pharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT krennliselotte pharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid
AT njamendieudonne pharmacologicaloverviewofalpinumisoflavoneanaturalprenylatedisoflavonoid